Dr Sarah Hayes, one of our early career researchers who specializes in proteomics research, was awarded a Sydney Vital Travel Grant to attend the 17th Human Proteome Organisation (HUPO) World Congress (Sept 30 – Oct 3, 2018) with her presentation – “High Resolution Protein Mapping of ROS1 NSCLC cell lines: defining mechanisms of acquired crizotinib resistance”.
The Human Proteome Organisation (HUPO) is a scientific organization representing and promoting proteomics through international cooperation and collaborations by fostering the development of new technologies, techniques and training.
This year’s HUPO annual congress, held in Orlando, Florida, brought together global research cohorts of Dr Hayes and saw over 30 sessions covering a wide range of topics such as cancer proteomics, mass spec technologies and computational advances.
Highlights of the congress included:
2. Prof Koji Ueda’s research of developing diagnostic cancer “liquid biopsy” by analysing patient exosomes isolated form viable renal cell carcinoma.
3. Research from Prof Kwangsoo Kim’s team from South Korea who used proteomic-based machine learning computational analysis to identify biomarkers predictive of chemotherapeutic responses in the archived human breast cancer samples.
Dr Hayes also notes that by participating in programs and workshops focusing on industry communication, she has gained further understanding into how proteomics should be translated into improving cancer patient outcomes. Attending the HUPO World Congress has allowed Dr Hayes to build a wider network with other scientists and to gain advice on new experimental techniques that is necessary for her current projects. Sydney Vital would like to congratulate Dr Hayes on presenting at the HUPO World Congress and encourage her to continue her outstanding research.
Keep up-to-date with our scholarships, funding and awards and check out our grant schemes here.